Why the study?
Does the RISK-PCI score improve prediction of 30-day MACE and death in ACS patients compared to GRACE and TIMI scores?
Does the RISK-PCI score improve prediction of 30-day MACE and death in ACS patients compared to GRACE and TIMI scores?
The RISK-PCI score is a valid alternative to GRACE and TIMI scores for predicting 30-day outcomes in ACS patients, with the unique advantage of predicting recurrent ischemia requiring TVR.
Supports RISK-PCI as an alternative ACS predictor; leaves open prospective validation before clinical adoption.
In comparison with the GRACE and TIMI scores, RISK-PCI score showed a non-inferior ability to predict 30-day MACE and death in ACS patients. Moreover, RISK-PCI was the only scoring system that could predict recurrent ischemia requiring TVR.
No takes yet. Share an insight, caveat, or question.
Jakimov et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: